Buprenorphine and Naloxone — 8/2MG, Tablet, bottle of 30 tablets

Buprenorphine and Naloxone — 8/2MG, Tablet, bottle of 30 tablets

Buprenorphine and Naloxone is a tablet for sublingual use. Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support.

• Active ingredient or product type: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE
• Strength/concentration: 8/2MG
• Dosage form and route: Tablet, Sublingual
• Exact package presentation: bottle of 30 tablets
• NDC/item number: 42858-602-03
• Manufacturer: RHODES PHARMA
• Storage/handling: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store Buprenorphine and Naloxone Sublingual Tablets securely and dispose of properly [see Patient Counseling Information (17) ].
• Status: Rx only

Important safety information: Addiction, Abuse, and Misuse: Buprenorphine can be abused in a similar manner to other opioids.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.